MarketInOut Stock Screener Log In | Sign Up

Lasa Supergenerics Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026
Lasa Supergenerics Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization246 mln
Float30.54 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.27
Reliable

Relative Strength

0 / 100
Severely lagging

Debt / Equity

0.20
Very low leverage

Pre-Tax Margin

-245%
Severely loss-making

ROE

-26.18
Deeply negative

Business Description

Founded in 2016 and headquartered in Ratnagiri, India, Lasa Supergenerics Limited develops, manufactures, and sells a broad range of healthcare products for both humans and animals. The company produces active pharmaceutical ingredients used primarily in treating parasitic conditions, along with nutritional additives for animal feed and therapeutic reagents. Its products reach customers both within India and through international exports.

Key Fundamentals

EPS-0.80
ROE-26.18
RPS1.30
ROIC-18.42
ROA-20.66
Interest Cover-28.66
EBITDA, mln-90.32
EV / EBITDA-4.15
EV / EBIT-2.49
Revenue, mln63.56
EV / Revenue5.89

Quote Details

Last 4.67
Change -0.24 (-4.89%)
Open 4.86
Volume 42,111
Turnover 196,658
Average Volume 38,162

Financial Ratios

Pre-Tax Profit Margin-245
Current Ratio0.62
Price / Book0.57
Price / Tangible Book0.86
Price / Cash Flow95.09
Debt / Equity0.20
Price / Sales4.47

Financial Strength

Altman Z-Score-1.77
Piotroski F-Score 3 / 9
Beneish M-Score-3.27
Price to Intrinsic Value0.50
Shiller PE Ratio0.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -20.71% 2 / 100   
1 Month -33.19% 1 / 100   
2 Months -34.59% 5 / 100   
6 Months -36.03% 8 / 100   
1 Year -59.64% 5 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog